Susanne Glowienke
Preclinical Safety Europe
Novartis Pharma AG
MUT-2881.2.29
CH 4002 Basel
Switzerland
Name/email consistency: high
- Structure-activity considerations and in vitro approaches to assess the genotoxicity of 19 methane-, benzene- and toluenesulfonic acid esters. Glowienke, S., Frieauff, W., Allmendinger, T., Martus, H.J., Suter, W., Mueller, L. Mutat. Res. (2005)